EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of combined treatment with Sodium valproate and methylprednisolone on neurological recovery after experimental spinal cord injury

Yakun Du, Jianwei Sun, Xinming Yang

Cellular and Molecular Biology · 2025

DOI: 10.14715/cmb/2025.71.3.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2025. Verfasst von Yakun Du und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hebei Children's Hospital, Shijiazhuang, Hebei, 050031, China. yxm11200@126.com. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Methylprednisolone, Valproic Acid, Recovery of Function. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to investigate the effect of Sodium valproate (VAP) combined with methylprednisolone (MP) on spinal cord injury (SCI), and its underlying mechanism. Following the establishment of the SCI model using SD mice, VPA treatment group: 8 hours after the establishment of SCI model, VAP (dissolved in normal saline) was injected intraperitoneally at a dose of 300 mg/kg for 30 days. MP treatment group: 30min, 6 and 24 hours after successful establishment of SCI model, MP (dissolved in normal saline) was injected intraperitoneally at a dose of 30 mg/kg. Behavioral tests, Nissl staining, and H&E staining were employed to assess motor function recovery and neuronal cell death. Western blot was used to assess the apoptosis-associated proteins (Bcl-2, caspase-3, Bax). They showed VAP combined with MP can significantly improve the motor function of spinal cord and reduce neuronal death. Also, significant upregulation of Bcl-2 expressions, with the downregulation of Bax and caspase-3 expressions were found in the VAP combined with MP treated group. This study aims to explore the mechanism of VAP combined with MP in the treatment of SCI. The findings of this study the protective effect of MP combined with MP on SCI may be mediated by inhibition of NF- κ B signal pathway. These results demonstrate the therapeutic potential of VAP combined with MP in SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesMethylprednisoloneValproic AcidRecovery of FunctionAnimalsMiceApoptosisbcl-2-Associated X ProteinDisease Models, AnimalCaspase 3Proto-Oncogene Proteins c-bcl-2Neuroprotective AgentsDrug Therapy, CombinationMaleSpinal CordNeurons

Substanzen

MethylprednisoloneValproic Acidbcl-2-Associated X ProteinCaspase 3Proto-Oncogene Proteins c-bcl-2Neuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurology, Hebei Children's Hospital, Shijiazhuang, Hebei, 050031, China. yxm11200@126.com.
  • Department of Spine Orthopedics, Handan Campus, North China Medical Fengfeng General Hospital, Jizhong Energy, Handan 056200, China. yxm11200@126.com.
  • Department of Orthopaedics, First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, 075061, China. yxm11200@126.com.

Zitieren

APA

Du, Y., Sun, J., & Yang, X. (2025). Effect of combined treatment with Sodium valproate and methylprednisolone on neurological recovery after experimental spinal cord injury. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2025.71.3.2

Vancouver

Du Y, Sun J, Yang X. Effect of combined treatment with Sodium valproate and methylprednisolone on neurological recovery after experimental spinal cord injury. Cellular and Molecular Biology. 2025. doi:10.14715/cmb/2025.71.3.2

BibTeX
@article{Du2025,
  author = {Du, Yakun and Sun, Jianwei and Yang, Xinming},
  title = {Effect of combined treatment with Sodium valproate and methylprednisolone on neurological recovery after experimental spinal cord injury},
  journal = {Cellular and Molecular Biology},
  year = {2025},
  doi = {10.14715/cmb/2025.71.3.2}
}
Kostenlos starten →